Highlight
– In a retrospective cohort of 159,943 US men with prostate cancer (2000–2015), estimated travel time to the treating facility ≥30 minutes was associated with lower adjusted risks of all-cause (aHR 0.91, 95% CI 0.89–0.93) and prostate cancer–specific mortality (aHR 0.90, 95% CI 0.86–0.95).
– The authors suggest this counterintuitive finding may reflect higher-quality or more specialized care concentrated at centers that draw patients from greater distances.